Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07201831 · ClinicalTrials.gov registry record
A Multi-country, Cross-sectional Quantitative Study Exploring Awareness, Understanding, and Perceptions of the Relation Between Cardiorenal Metabolic Conditions and MASLD/MASH Among Healthcare Providers, People With MASLD/MASH, and At-risk Population
A clinical trial, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- 1,330
- Enrollment target
NCT07201831: Completed study, sponsored by Novo Nordisk A/S.
NCT07201831 is a clinical trial that has completed, run by Novo Nordisk A/S. The registered enrollment target is 1,330 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07201831 has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- 1,330 participants
- Enrollment target
Study Summary
The purpose of this study is to collect information for scientific research and to better understand awareness and to understand overall risk awareness, diagnoses and treatment related to liver related diseases. The study aims to collect valid responses through online questionnaires from the participants. This study is a survey-based study without collection of laboratory data. It will take the participant 25 minutes to complete the survey. The study is not related to any specific treatment options or pharmaceutical product.
Primary Outcome
Healthcare Provider (HCP) Quantitative Segment 7-point Likert scale 1 indicates very strongly disagree and 7 indicates very strongly agree
Interventions
- OTHER No treatment given
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,330 participants |
| Start Date | 2025-10-02 |
| Est. Completion | 2026-01-17 |
What the finished NCT07201831 record still lists
NCT07201831 is an observational study that tracks outcomes without assigning an intervention. Its 1,330 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which No treatment given is the first listed.
NCT07201831 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07201831 about?
NCT07201831 is a clinical study titled "A Multi-country, Cross-sectional Quantitative Study Exploring Awareness, Understanding, and Perceptions of the Relation Between Cardiorenal Metabolic Conditions and MASLD/MASH Among Healthcare Providers, People With MASLD/MASH, and At-risk Population". The purpose of this study is to collect information for scientific research and to better understand awareness and to understand overall risk awareness, diagnoses and treatment related to liver related diseases. The study aims to collect valid responses through online questionnaires from the partici...
What is the current status of trial NCT07201831?
This trial is currently completed. The enrollment target is 1,330 participants. The study started on 2025-10-02. Estimated completion is 2026-01-17.
What interventions are being tested in trial NCT07201831?
The interventions under investigation include: No treatment given (OTHER).
Who is sponsoring clinical trial NCT07201831?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05536011 · 1,329 participants
WAKIX® (Pitolisant) Pregnancy Registry
- NCT05415761 · 1,332 participants · NA
Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care
- NCT05511298 · 1,332 participants
Empowering Students Project
- NCT06934876 · 1,332 participants
Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI